The COVID-19 impact on severe uncontrolled asthma costs and biologic use.

Overview of attention for article published in Allergy and Asthma Proceedings, September 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 4 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 243 followers.

RT @Najm__Khan: Proud to share our investigation that reports on the impact of COVID-19 on healthcare costs and biologic use for Severe Unc…

30 Sep 2023

Reply Repost Favourite

Proud to share our investigation that reports on the impact of COVID-19 on healthcare costs and biologic use for Severe Uncontrolled Asthma patients. A great team effort! @RWJMS @ritmsrbhs @njacts https://t.co/odvnkswe3l

04 Sep 2023

Reply Repost Favourite

The COVID-19 impact on severe uncontrolled asthma costs and biologic use. https://t.co/paFDnKkVop

31 Aug 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.